Duffy Sean P.'s Form 4 filing
Omada Health, Inc. (OMDA) · filed Jan 14, 2026
- Accession no.
- 0001610717-26-000015
- Filed
- Jan 14, 2026
- Trade date
- Jan 12-13, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.25M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Duffy Sean P.CIK 0002069522 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Common Stock | MOption exerciseAcquired | +230,479 | $2.55 | +$587,721.45 | 357,123 | Direct | |
| Jan 12, 2026 | Common Stock | SSaleDisposed | −139,989 | $15.35F2 | −$2,148,831.15 | 217,134 | Direct | |
| Jan 12, 2026 | Common Stock | SSaleDisposed | −90,490 | $15.99F3 | −$1,446,935.1 | 126,644 | Direct | |
| Jan 13, 2026 | Common Stock | MOption exerciseAcquired | +40,796 | $2.55 | +$104,029.8 | 167,440 | Direct | |
| Jan 13, 2026 | Common Stock | SSaleDisposed | −40,796 | $15.95F4 | −$650,696.2 | 126,644 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Common Stock | MOption exerciseDisposed | −230,479 | $0.00 | $0 | 40,796 | Direct | |
| Jan 13, 2026 | Common Stock | MOption exerciseDisposed | −40,796 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $14.85 to $15.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $15.85 to $16.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $15.61 to $16.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.